Bath & Body Works (NYSE:BBWI) Given New $30.00 Price Target at Evercore ISI

Bath & Body Works (NYSE:BBWI) had its price objective trimmed by Evercore ISI from $40.00 to $30.00 in a research report released on Friday morning, Benzinga reports. The firm currently has an in-line rating on the stock.

BBWI has been the subject of a number of other research reports. JPMorgan Chase & Co. lowered Bath & Body Works from a neutral rating to an underweight rating and lowered their price objective for the company from $41.00 to $27.00 in a research note on Tuesday, October 24th. Citigroup raised their price target on Bath & Body Works from $38.00 to $40.00 and gave the stock a neutral rating in a report on Wednesday, August 16th. Telsey Advisory Group cut their target price on Bath & Body Works from $52.00 to $42.00 and set an outperform rating on the stock in a research note on Friday. Barclays upgraded Bath & Body Works from an equal weight rating to an overweight rating and lifted their price target for the company from $41.00 to $45.00 in a research report on Tuesday, August 1st. Finally, Jefferies Financial Group cut Bath & Body Works from a buy rating to a hold rating and decreased their target price for the stock from $45.00 to $30.00 in a report on Thursday, October 26th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Hold and a consensus target price of $41.73.

Bath & Body Works Trading Down 1.0 %

NYSE BBWI opened at $29.06 on Friday. The business’s 50-day moving average price is $31.85 and its 200 day moving average price is $35.21. Bath & Body Works has a twelve month low of $27.30 and a twelve month high of $49.55. The company has a market capitalization of $6.61 billion, a PE ratio of 9.11, a price-to-earnings-growth ratio of 1.04 and a beta of 1.84.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, November 16th. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.13. Bath & Body Works had a negative return on equity of 32.64% and a net margin of 9.90%. The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the firm earned $0.40 earnings per share. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. Equities analysts predict that Bath & Body Works will post 3.08 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Friday, November 17th will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.75%. The ex-dividend date is Thursday, November 16th. Bath & Body Works’s dividend payout ratio (DPR) is currently 25.08%.

Institutional Trading of Bath & Body Works

Several institutional investors have recently modified their holdings of BBWI. Cambridge Investment Research Advisors Inc. boosted its holdings in Bath & Body Works by 12.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 19,672 shares of the company’s stock valued at $940,000 after purchasing an additional 2,228 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Bath & Body Works by 3.9% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 34,484 shares of the company’s stock valued at $1,648,000 after purchasing an additional 1,301 shares in the last quarter. Vontobel Holding Ltd. boosted its stake in Bath & Body Works by 253.4% during the first quarter. Vontobel Holding Ltd. now owns 44,967 shares of the company’s stock worth $2,244,000 after acquiring an additional 32,242 shares in the last quarter. Candriam Luxembourg S.C.A. boosted its stake in Bath & Body Works by 127.4% during the first quarter. Candriam Luxembourg S.C.A. now owns 27,922 shares of the company’s stock worth $1,335,000 after acquiring an additional 15,642 shares in the last quarter. Finally, Baird Financial Group Inc. lifted its stake in shares of Bath & Body Works by 54.3% in the first quarter. Baird Financial Group Inc. now owns 113,805 shares of the company’s stock worth $5,440,000 after buying an additional 40,046 shares in the last quarter. Institutional investors own 94.31% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.